Experimental Drug Provides Lasting Relief For Bleeding Condition

blood

Key Takeaways

  • An experimental drug can help many with a rare autoimmune bleeding condition

  • More than half of people with immune thrombocytopenia wound up with healthy platelet levels after treatment with ianalumab

  • The drug’s benefits lasted up to a year

Originally published on healthday.com, part of the BLOX Digital Content Exchange.

Recommended for you